174 related articles for article (PubMed ID: 6605342)
1. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
Senogles SE; Nelsestuen GL
J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
[TBL] [Abstract][Full Text] [Related]
2. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
Timmons S; Kloczewiak M; Hawiger J
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
[TBL] [Abstract][Full Text] [Related]
3. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
4. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
Phillips MD; Moake JL; Nolasco L; Turner N
Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193
[TBL] [Abstract][Full Text] [Related]
5. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
Kao KJ; Pizzo SV; McKee PA
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
[TBL] [Abstract][Full Text] [Related]
6. Platelet-binding of the von Willebrand factor.
Green D; Muller HP
Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
[TBL] [Abstract][Full Text] [Related]
7. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
De Marco L; Girolami A; Russell S; Ruggeri ZM
J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
Levine SP; Moake JL
Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
[TBL] [Abstract][Full Text] [Related]
9. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
10. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
[TBL] [Abstract][Full Text] [Related]
11. Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding.
LaDuca FM; Bettigole RE; Bell WR; Robson EB
Blood; 1986 Oct; 68(4):927-37. PubMed ID: 3489493
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
13. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
14. Comparison of thrombin and ristocetin in the interaction between von Willebrand factor and platelets.
Harrison RL; McKee PA
Blood; 1983 Aug; 62(2):346-53. PubMed ID: 6307433
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
16. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
Olson JD; Zaleski A; Herrmann D; Flood PA
J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
[TBL] [Abstract][Full Text] [Related]
17. Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets.
Ruggeri ZM; Bader R; de Marco L
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6038-41. PubMed ID: 6310559
[TBL] [Abstract][Full Text] [Related]
18. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
[TBL] [Abstract][Full Text] [Related]
19. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
[TBL] [Abstract][Full Text] [Related]
20. Localization of surface vWF on resting and stimulated platelets.
Rand JH; Gordon RE; Uson RR; Potter BJ
Blood; 1987 Nov; 70(5):1297-302. PubMed ID: 2822169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
